Smart Inhalers Market: size and forecast, segments, key players

Drawn from Smart Inhalers Market by Product (Inhalers and Nebulizers), Indication (Asthma and COPD), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2019 - 2026, 185 pages. Every figure, segment and company below is stated in that report.

Market size and forecast

The global smart inhalers market size was valued at $34 million in 2018 and is estimated to reach $1,406 million by 2026, growing at a CAGR of 58.4% from 2019 to 2026.

How the market is segmented

By Product

• Inhalers
• Metered Dose Inhalers
• Dry Powder Inhalers

Companies the report covers

• AstraZeneca, plc.,
• GlaxoSmithKline, plc,
• Novartis International AG,
• Adherium Limited,
• Boehringer Ingelheim Group,
• Cohero Health Group

Regions covered

• North America
• U.S.
• Canada
• Mexico

What the report contains

1. Chapter 1: Introduction
2. Chapter 2: Executive Summary
3. Chapter 3: Market Overview
4. Chapter 4: Smart Inhalers Market, BY Product
5. Chapter 5: Smart Inhalers Market, BY Indication
6. Chapter 6: Smart Inhalers Market, BY Distribution Channel
7. Chapter 7: Smart Inhalers Market, BY Region
8. Chapter 8: Company Profiles
9. List OF Tables
10. List OF Figures

Full report, table of contents and licence options →